Consumer: Page 3

COVID drives 10X growth in molecular point-of-care market
By Bruce Carlson
The 2021 figure represents 10 times growth in revenues from 2019, when molecular diagnostics were primarily being used by urgent care centers to determine flu and for hospitals looking to reduce antibiotic prescription. The COVID-19 pandemic and constant arrival of variants are the determining factor, and the continued presence of COVID will be a factor in the market.
April 13, 2022
2020 08 10 15 31 8350 Coronavirus Business Graphic2 400
Invitae launches personalized cancer monitoring platform
By LabPulse.com staff writers
The assays can help clinicians assess patient risk, treatment response, and predict recurrence, the company said. Invitae developed the platform in collaboration with the Tracerx consortium at University College London.
March 20, 2022
2021 01 12 23 44 3780 Blood Test Samples Lab 400
Proscia, Siemens ink digital pathology deal
By Melissa Busch
Under the deal, Siemens Healthineers will expand its enterprise imaging offering into the global digital pathology market using Proscia’s Concentriq Dx platform. The agreement with Proscia enables Siemens Healthineers to expand into one of the few remaining areas of healthcare that is left to begin experiencing the full benefits of digitization.
March 16, 2022
2021 02 18 22 06 7241 Pathology Digital Workstation 20210218225213
Intrivo's COVID-19 test now available
By LabPulse.com staff writers
The antigen test delivers results with 98.2% accuracy in 15 minutes and detects all major known variants, including omicron, the company said. On/Go One is available on Amazon and at letsongo.com for rapid delivery direct to consumers' homes.
March 2, 2022
2020 01 21 22 13 2411 Virus Coronavirus 400
Variantyx secures $41.5M for precision oncology platform
By LabPulse.com staff writers
Variantyx is developing platforms for whole-genome sequencing and analysis that will allow healthcare providers to better understand the genetic makeup of patients. The company's products will use multiple genomic technologies to analyze and identify the genetic alterations in tumors, generating information that can help predict patient response to treatment.
February 13, 2022
2021 01 27 00 33 2291 Genome Sequence Barcode 400
SPT Labtech debuts liquid handling platform at SLAS 2022
By LabPulse.com staff writers
Called firefly, the platform brings pipetting and dispensing together within a compact all-in-one design. The platform offers multiple user levels, intelligent programming, and a transparent audit trail while a peer-to-peer cloud-based network allows researchers to share their custom protocols.
February 8, 2022
2022 02 09 19 27 5289 2022 02 09 Spt Labtech 400
Gate Scientific highlights new products at SLAS 2022
By LabPulse.com staff writers
The company's stir bars make up the wireless SmartSense platform. They are used for temperature, pH, and spin sensing, as well as part of the company's digital programmable chemical lab station for heating, stirring, wireless sensing, remote control, and monitoring.
February 3, 2022
2020 02 13 23 04 0191 Lab Scientists 400
CMS will cover free over-the-counter COVID-19 tests
By Will Morton
No date has been established, yet CMS said by early spring Medicare beneficiaries will be able to access up to eight over-the-counter COVID-19 tests per month for free at local pharmacies and other participating facilities. The policy applies to tests cleared by the U.S. Food and Drug Administration (FDA).
February 2, 2022
2020 03 13 20 59 0533 White House 400
Biden orders private payers to cover at-home COVID tests
By LabPulse.com staff writers
The move comes as the spread of the omicron variant of SARS-CoV-2 is putting a strain on testing capacity in the U.S. Many testing labs are overstretched, and consumers are finding it increasingly difficult to find over-the-counter COVID-19 tests.
January 9, 2022
2020 03 18 20 13 7386 Virus Coronavirus Covid 19 400
Nova named president of Veracyte's CLIA U.S. business
By LabPulse.com staff writers
Nova will lead all aspects of Veracyte's CLIA business for all diagnostic tests that are performed in the company's laboratories and serve physicians and their patients in the U.S. These aspects include market development, product marketing, payer reimbursement, sales, and operations.
January 6, 2022
2020 10 14 15 59 9456 Business Woman Handshake 400
Natera to expand into early cancer detection
By LabPulse.com staff writers
In November 2021, Natera announced exclusive access from Aarhus University to a biobank of up to 40,000 prospectively collected colorectal cancer screening samples for the development and validation of Natera's early cancer detection products. The database of samples is expected to help accelerate the introduction of Natera's products to market and potentially support key commercial milestones, the company said.
January 5, 2022
2019 10 09 17 32 0093 Dna Cancer Cell 400
GattaCo appoints new executives
By LabPulse.com staff writers
Pankaj Singhal, PhD, is the company's new president and CEO, and Chris Parker has been named director of the company's board. Singhal previously held roles with Exact Sciences and GenMark Diagnostics and has led the development and commercialization of several clinical diagnostics platforms.
January 5, 2022
2020 03 10 00 02 9515 Delivery Package Box 400
Previous Page
Page 3 of 8
Next Page